Filho OM, Giobbie-Hurder A, Lin NU, Faggen M, et al. A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer. Breast Cancer Res Treat 2020 Oct 6. pii: 10.1007/s10549-020-05928.
PMID: 33025482